Dr Reddy's lab completes phase-1 trials on anti-cancer compound
Dr Reddy's Laboratores, a pharmaceutical company, has completed the phase-1 clinical tirals on its anti-cancer compound DRF-1042, which is its first new chemical entity (NCE) in the cancer area.The